Compounded semaglutide
Sold by T2D.com · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$99
| Medication · Bring Your Own Prescription (BYOP) | $99 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Bring Your Own Prescription (BYOP) “Price $170 $99 Month (0.25 /0.50) compounded Semaglutide” | Per month$99 | Charged today$99 |
We earn nothing from this link. T2D.com has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Both |
|---|---|
| Cancellation | “You can cancel a Subscription by visiting your "Account" on the Services. You will be responsible for all Subscription Fees incurred for the then-current Subscription period.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from t2d.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — T2D.com never names the drug for its main 'Use Our Prescribers' plan on the pricing block (elsewhere the site says it offers compounded Semaglutide and Tirzepatide generally), so that $170/mo entry is recorded as unspecified GLP-1. Form (vial vs pen) is never stated. About-us and contact-us paths 404'd; /pricing, /faq and /plans also 404'd -- pricing lives at /weight-loss instead.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.